Home

Regulated Information

Financial Reports

23

Mar
2023

Full year 2022 annual financial report

  • FR

  • FR

04

Sep
2023

Half year 2023 financial report

  • FR

24

Mar
2022

Annual Report 2021

  • FR

  • FR

24

Mar
2022

Full Year 2021 Annual Report & Business Highlights

  • FR

06

May
2022

Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights

  • FR

05

Aug
2022

Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights

  • FR

10

Nov
2022

Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights

  • FR

25

Mar
2021

Full Year 2020 Annual Report & Business Highlights

  • FR

31

Mar
2021

Annual Report 2020

  • FR

06

May
2021

First Quarter 2021 Financial Results and Recent Business Highlights

  • FR

04

Aug
2021

Half Year 2021 Financial Results & Business Highlights

  • FR

10

Nov
2021

Third Quarter 2021 Financial Results and Recent Business Highlights

  • FR

22

Mar
2020

Full Year 2019 Annual Report

  • FR

02

Apr
2020

Annual Report 2019

  • FR

07

May
2020

First Quarter 2020 Financial Results and Recent Business Highlights

  • FR

06

Aug
2020

Half Year 2020 Financial Results and Business Highlights

  • FR

10

Nov
2020

Third Quarter 2020 Financial Results and Recent Business Highlights

  • FR

28

Mar
2019

Full Year 2018 Financial and Operating Results

  • FR

05

Apr
2019

Annual Report 2018

  • FR

09

May
2019

First Quarter 2019 Financial Results and Recent Business Highlights

  • FR

22

Aug
2019

Interim Financial Report H1.2019

  • FR

19

Nov
2019

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

  • FR

22

Mar
2018

Full year 2017 Financial and Operating Results

  • FR

06

Apr
2018

Annual report 2017

  • FR

15

May
2018

First Quarter 2018 Financial Results and Recent Business Highlights

  • FR

23

Aug
2018

First Half 2018 Financial Results and Operational Progress

  • FR

21

Nov
2018

Third Quarter 2018 Business Update

  • FR

23

Mar
2017

Celyad Reports 2016 Financial and Operating Results

  • FR

19

May
2017

First Quarter 2017 Business Update

  • FR

26

May
2017

Celyad’s Annual Report 2016

  • FR

29

Aug
2017

First Half 2017 Financial statements and operational progress

  • FR

06

Apr
2016

AR 2015 Annual report

  • EN

20

May
2016

Q1 2016 Business Update

  • EN

25

Aug
2016

Celyad 2016 First Half Year Report

  • FR

18

Nov
2016

Q3 2016 Business Update

  • FR

30

Jun
2015

H1 2015 Interim Financial Report

  • FR

19

Nov
2015

Q3 2015 Business Update

  • FR

SEC Filings

Filter

Filing Date Form Description Filing Group Downloads
August 4, 2021 6-K Celyad Oncology Reports First Half 2021 Financial Results And Recent Business Highlights
July 21, 2021 6-K Celyad Oncology Presents Updates on Allogeneic CAR T Clinical Candidates and shRNA-based Preclinical Concepts at Research & Development Day
June 11, 2021 6-K Celyad Oncology Presents Preliminary Data From Phase 1 IMMUNICY-1 Trial Of ShRNA-Based Allogeneic CAR T Candidate CYAD-211 In r/r MM At The EHA Virtual Congress
May 12, 2021 6-K Report of Foreign Issuer Current reports
May 7, 2021 6-K Report of Foreign Issuer Current reports
March 25, 2021 20-F Annual and Transition Report (foreign private issuer) Other

Regulated Information

Filter

Transparency Notification dated Nov 28, 2023

Transparency Declaration | December 4th, 2023

Transparency Notification dated Nov 17, 2023

Transparency Declaration | November 21st, 2023

Transparency Notification dated Sep 13, 2023

Transparency Declaration | September 15th, 2023